Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes
More News related to ABAX
- Abaxis, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference
- Abaxis, Inc. to Present at the Stephens Inc. Fall Investment Conference
- Matrix Lighthouse Rating Changes 10/29
- Morning Movers 10/28: Apria (AHG) Higher on Expected Merger Closing, PAREXEL (PRXL) Sinks On Guidance
- After-Hours Movers 10/27: Buffalo Wild Wings (BWLD) Lower After Results, Harmonic (HLIT) Higher
More News related to AFFX
- Researchers Use Affymetrix Technology to Discover Why Some Breast Cancer Patients Resist Tamoxifen
- Affymetrix to Webcast Presentation at Piper Jaffray Healthcare Conference
- Notable Mergers and Acquisitions of the Day 11/11: CHK/STO, ELRN/ENDO, AFFX
- Affymetrix (AFFX) Announces DMET(TM) Plus Premier Pack; to Acquire Panomics for $73M in Cash
- Affymetrix to Acquire Panomics
More News related to AMAG
- Unusual 11 Mid-Day Movers 11/13: AMAG, OPTR, CBG, GSOL Higher; WCG, CROX, FEED, PERY Lower
- Morning Movers 11/13: WellCare Health (WCG) Lower on 10-Q Delay, Intel's (INTC) Warning Hurts Tech
- FDA Designates NDA for AMAG Pharma's (AMAG) Ferumoxytol as Complete; FDA Sets Dec. 30 PDUFA Date
- AMAG Pharmaceuticals (AMAG) Announces Ferumoxytol Resubmission Designated Complete, Class 1 Response by the FDA
- AMAG Pharmaceuticals Announces Ferumoxytol Resubmission Designated Complete, Class 1 Response by the FDA
More News related to Press Releases
- NovaMed (NOVA) Acquires 65% Interest in Physicians Surgical Center
- Sierra Wireless (SWIR) Enters Agreement To Merge With Wavecom (WVCM)
- Parker Hannifin (PH) Buys Brazilian Manufacturer of Connectors and Instrumentation Products
- Lydall (LDL) Acquires DSM Solutech B.V.; Sees Deal Accretive Within First 12 Months
- Parker Hannifin (PH) Acquires Detroit Plasticos e Metais; Sees Deal Accretive After First Year
NEW YORK, Oct. 10 /PRNewswire/ -- Mergent, Inc., administrator for the HealthShares(TM) Indexes, a series of 5 underlying indexes for the HealthShares(TM) Exchange Traded Funds, today announced the quarterly rebalancing of the Indexes. This is the first rebalance of the funds reflecting the revised Index Methodologies. The following securities will be added and deleted in the Indexes effective before the opening of trading on NYSE Arca on October 21, 2008.
(Logo: http://www.newscom.com/cgi-bin/prnh/20080204/CLM073LOGO ) HealthShares(TM) Cancer Index (HHK) Drop NEUROSEARCH A/S (OMX Nordic Exchange Copenhagen: NEUR) Add ARIAD PHARMACEUTICALS INC (NASDAQ: ARIA) BTG (London Main Market, U.K.: BGC) CYTOKINETICS INC (NASDAQ: CYTK) CHUGAI PHARM CO (Tokyo SE: 4519) ENZON PHARMACEUTICALS INC. (NASDAQ: ENZN) EXELIXIS INC (NASDAQ: EXEL) GERON CORP (NASDAQ: GERN) GTX INC (NASDAQ: GTXI) HALOZYME THERAPEUTICS INC. (NASDAQ: HALO) LIGAND PHARMACEUTICALS INC (NASDAQ: LGND) NEKTAR THERAPEUTICS (NASDAQ: NKTR) HealthShares(TM) Diagnostics Index (HHD) Drop DIASORIN SPA (Borsa Italiana MTA: DIA) ORION CORPORATION (OMX Nordic Exchange Helsinki: ORNAV) Add ABAXIS INC. (NASDAQ: ABAX) AFFYMETRIX INC. (NASDAQ: AFFX) AMAG PHARMACEUTICALS INC. (NASDAQ: AMAG) ANGIODYNAMICS INC. (NASDAQ: ANGO) ENZO BIOCHEM INC. (NYSE: ENZ) GIVEN IMAGING LTD (NASDAQ: GIVN) MERIT MEDICAL SYSTEMS INC. (NASDAQ: MMSI) NATUS MEDICAL INC (NASDAQ: BABY) NEOGEN CORP (NASDAQ: NEOG) NIGHTHAWK RADIOLOGY (NASDAQ: NHWK) QUIDEL CORP (NASDAQ: QDEL) SONOSITE INC (NASDAQ: SONO) TOMOTHERAPY INC (NASDAQ: TOMO) TOPCON CORPORATION (Tokyo SE: 7732) VOLCANO CORPORATION (NASDAQ: VOLC) HealthShares(TM) Drug Discovery Tools Index (HHV) Drop BIODEL INC (NASDAQ: BIOD) Add ARIAD PHARMACEUTICALS INC (NASDAQ: ARIA) CYTOKINETICS (NASDAQ: CYTK) ENZON PHARMACEUTICALS INC. (NASDAQ: ENZN) I-FLOW CORP (NASDAQ: IFLO) INSULET CORP (NASDAQ: PODD) MANNKIND CORP (NASDAQ: MNKD) NEKTAR THERAPEUTICS (NASDAQ: NKTR) OBAGI MEDICAL PRODUCTS INC (NASDAQ: OMPI) VITAL IMAGES INC (NASDAQ: VTAL) HealthShares(TM) European Drugs Index (HRJ) Drop SCHWARZ PHARMA AG (Frankfurt, Germany: SRZ GR) PRONOVA BIOPHARMA (Oslo, Norway: PRON) Add BTG (London Main Market, U.K.: BGC) CRUCELL NV (Euronext, Amsterdam: CRXL) ELAN CORP (Irish Main Market, Ireland: DRX) EURAND N.V. (NASDAQ: EURX) MEDIGENE AG (Frankfurt, Germany: MDG) MORPHOSYS (Frankfurt, Germany: MOR) NEUROSEARCH A/S (OMX Nordic Exchange Copenhagen: NEUR) NICOX SA (Euronext, Paris: COX)
The rebalanced Indexes, including the rebalanced Index Shares, are based on the closing prices as of October 9, 2008.
In accordance with the Exemptive Order, a complete list of the constituents reflecting the rebalancing will be posted at: http://www.xsharesadvisors.com/healthshares/content/view/53/274/
About Mergent
Mergent, Inc. is a leading provider of business and financial data on global publicly listed companies. Based in the U.S., the company maintains a strong global presence, with offices in New York, Charlotte, San Diego, London, Tokyo and Melbourne.
Founded in 1900, Mergent operates the longest continuously collected database of: descriptive and fundamental information on domestic and international companies; pricing and terms and conditions data on fixed income and equity securities; and corporate action data. In addition, Mergent develops and licenses equity and fixed income investment products based on its proprietary investment methodologies. Mergent-licensed products have approximately $3.5 billion in assets under management and are offered by major investment management firms. Mergent's index calculation platform is the chosen technology for some of the world's largest index companies. Its index calculation and pricing distribution protocols are used to administer index rules and distribute real-time pricing data.
For more information, please visit www.mergent.com and www.dividendachievers.com .
SOURCE Mergent, Inc.
Related Categories
Press ReleasesStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
